Anna-Léa Kahn - Concepedia

Author

Anna-Léa Kahn

World Health Organization ORCID

Also Known As

A Kahn, A. Kahn, A. Kah�n, A.-L. Kahn, Anna Lea Kahn, Anna-Lea Kahn, Anna-Léa Kahn, Merja Roivainen

Publications

673

Citations

H-Index

Concepts

All Affiliations

World Health Organization Program for Appropriate Technology in Health World Health Organization Regional Office for Africa World Health Organization - Pakistan Centers for Disease Control and Prevention

About

Anna-Léa Kahn is an author at World Health Organization specializing in vaccination, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	216
2	Public Health	7	7	195
3	Epidemiology	4	4	119
4	Global Health	3	3	53
5	Health Policy	2	2	53

Anna-Léa Kahn

Publications

550

Citations

H-Index

Page 1

	Year	Citations
Priming after a Fractional Dose of Inactivated Poliovirus Vaccine Sonia Resik, Alina Tejeda, Roland W. Sutter, New England Journal of Medicine	2013	135
Poliovirus Excretion Among Persons With Primary Immune Deficiency Disorders: Summary of a Seven-Country Study Series Li Li, Olga E. Ivanova, Nadia Driss, The Journal of Infectious Diseases	2014	63
Predictors of incomplete immunization coverage among one to five years old children in Togo Dadja Essoya Landoh, Farihétou Ouro-kavalah, Issifou Yaya, BMC Public Health	2016	58
Polio vaccine hesitancy in the networks and neighborhoods of Malegaon, India Jukka‐Pekka Onnela, Bruce E. Landon, Anna-Léa Kahn, Social Science & Medicine VaccinationPolio Vaccine HesitancyDisease OutbreakVaccine EfficacyPublic Health	2016	50
Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines Anna-Léa Kahn, Debra Kristensen, R. Jagannatha Rao Vaccine VaccinationVaccine SafetyCross-protectionTemperature Chain UsePreventive Medicine	2017	34
Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka Rajiva de Silva, Sunethra Gunasena, D Ratnayake, Vaccine VaccinationPrimary ImmunodeficiencyChronic Poliovirus ExcretionVirologyChronic Viral Infection	2012	32
Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact? Birgitte Giersing, Anna-Léa Kahn, Courtney Jarrahian, Vaccine ImmunologyVaccine AccessibilityImmunotherapyPolicy AnalysisVaccine Hesitancy	2017	27
Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations Mercy Mvundura, Collrane Frivold, Anna Janik Osborne, Vaccine Vaccine HesitancyCross-protectionPreventive MedicineHealth CommunicationVaccine Surveillance	2021	26
The CAPACITI Decision-Support Tool for National Immunization Programs Siobhan Botwright, Birgitte Giersing, Martin I. Meltzer, Value in Health VaccinationVaccine SafetyImmunologyVaccine EfficacyInfection Control	2021	21
Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in Africa Zainab Waggie, Hennie Geldenhuys, Roland W. Sutter, The Journal of Infectious Diseases	2011	20

Page 1